GERMS MDPI

GERMS MDPI International peer-reviewed journal on infectious diseases in humans, published by MDPI.

Germs (ISSN 2248-2997) is an international, peer-reviewed journal dedicated to advancing knowledge and understanding in the field of infectious diseases in humans at the highest standards. The journal provides a platform for the dissemination of high-quality research, clinical insights, and public health perspectives that address the prevention, diagnosis, management, and control of infectious diseases worldwide. Germs publishes articles on a wide range of topics, describing research results in all areas connected to infectious diseases, including, but not limited to:

• Infectious diseases across clinical and public health domains
• Epidemiology of communicable diseases
• Clinical microbiology and applied virology
• Infection prevention and control
• Antimicrobial resistance and stewardship
• Vaccinology and immunization
• Diagnostics and biomarkers in infectious diseases
• Host–pathogen interactions and immunity
• Emerging and re-emerging pathogens
• Global health, One Health, and socio-economic determinants of infections
• Public health preparedness and outbreak response
• Policy, health systems, and ethics in infectious diseases

🎉 Exciting news! Our journal has been accepted into the   database! 📚This milestone is an important step in increasing t...
03/04/2026

🎉 Exciting news! Our journal has been accepted into the database! 📚

This milestone is an important step in increasing the visibility and impact of our work.

Grateful to everyone involved in supporting and developing the journal —this achievement wouldn’t have been possible without you.

For more details about the journal’s indexing and abstracting, feel free to visit: 🌐 https://brnw.ch/21x1ioR

30/03/2026
🌟 On Day 3 of the conference, Prof. Dr. Oana Sandulescu, our Editor-in-Chief, delivered an insightful presentation on cr...
28/03/2026

🌟 On Day 3 of the conference, Prof. Dr. Oana Sandulescu, our Editor-in-Chief, delivered an insightful presentation on creative and supportive , with a focus on effectively communicating , structuring scientific work, and improving academic writing skills.

Her session aimed to support all participants in further developing their abstracts, encouraging those with outstanding research to expand their work into full-length articles. We are excited to invite you to submit your work to the dedicated to this conference:

👉 Link: https://brnw.ch/21x18wc
⏰ Deadline: 15 December 2026
👥 Guest Editors: Prof. Dr. Oana Sandulescu and Prof. Dr. Streinu-Cercel Anca

We hope this initiative will inspire you to take your research further and open new scientific conversations with us. We encourage you to take advantage of this opportunity and reach out for any support at germs@mdpi.com 📩

We would like to extend our appreciation to our Guest Editors for this project and their valuable contribution and support.

Wish you success in your future publications, and look forward to reading your work! ✨

Day 1 of the   and   7th Edition has ended and here is a preview! 🎉We are grateful to everyone who attended and took the...
27/03/2026

Day 1 of the and 7th Edition has ended and here is a preview! 🎉

We are grateful to everyone who attended and took the time to visit our booth. We hope you enjoyed the sessions and had a great experience throughout the day.

We would like to thank Prof. Dr. Scheau Cristian and Dr. Diana Elena Vulpe for their vision and initiative, and for taking the time to visit us. Stay tuned for what’s coming next in the following months, as we are preparing an exciting new project focused on orthopaedic infections. 🎊

And last but not least, we would like to recognise Dr. Anna-Karina Felder, who joined our team last year as one of our first Early Career Editorial Board Members. We are delighted to have her with us and wish her success in her future plans. 👏

Thank you all for being part of this journey!

Davidoaie Mălina

🌍 Advancing   Care in Romania👉 Read:   Statement: Updated Recommendations for the Interdisciplinary Management of People...
27/03/2026

🌍 Advancing Care in Romania

👉 Read: Statement: Updated Recommendations for the Interdisciplinary Management of People Living with HIV in Romania

Available: https://brnw.ch/21x16VW

The care of people living with HIV in Romania largely aligns with international standards, particularly those of the European Clinical Society (EACS). Yet, translating guidelines into practice requires adapting to local clinical realities and fostering collaboration across medical specialities.🔎

📌In response, a dedicated team of experts spanning , , , , , and clinical came together to create a national consensus for interdisciplinary HIV management.

By uniting expertise across disciplines, this framework ensures that care is comprehensive, coordinated, and truly patient-focused.

🎓 Authors:
Oana Săndulescu, Anca Streinu-Cercel, Mariana Mărdărescu, Cristiana Oprea, Maria Dorobanţu, Gener Ismail, Aura Diana Reghina, Odette Chirilă, Extended Consensus Group and Adrian Streinu-Cercel

✨ HIV Advanced Training Forum – Day 1 ✨We’re happy to share that the first day of the   Advanced Training Forum has come...
26/03/2026

✨ HIV Advanced Training Forum – Day 1 ✨

We’re happy to share that the first day of the Advanced Training Forum has come to an end!

It was a pleasure to be part of such a meaningful event alongside an amazing team. We’re grateful to have inspiring people around us who make everything possible.🎉

🎗️At , we are truly fortunate to work with such a committed team, and today reflected that spirit.

We hope all participants enjoyed the sessions, and we look forward to continuing the discussions tomorrow.

We invite you to visit our booth to connect with us and learn more!

Special thanks to Oana Sandulescu, Streinu-Cercel Anca, Adriana Hristea, Casper Rokx and everyone else who stopped by our booth, it was a pleasure connecting with you in person. 🙏🏻

26/03/2026
Day 1 of the   &   Dialogues 7th Edition has officially started! 🎉📅 26-28 March📍The Palace of Parliament, Bucharest We w...
26/03/2026

Day 1 of the & Dialogues 7th Edition has officially started! 🎉

📅 26-28 March
📍The Palace of Parliament, Bucharest

We warmly welcome everyone attending the event — feel free to stop by our booth to connect with us and learn more about Germs and open access publishing.

It’s always a pleasure to meet passionate and driven students, and we’re grateful for the opportunity to connect in person.

💡 Recommended: A recent study published in Germs explores real-world experiences with a modern   regimen!🏅  /  /   (DOR/...
25/03/2026

💡 Recommended: A recent study published in Germs explores real-world experiences with a modern regimen!

🏅 / / (DOR/3TC/TDF) Treatment in People Living with : A Single-Center Real-World Experience from Belgrade, Serbia

🌐Link: https://brnw.ch/21x12Ma

📌In the era of modern (ART), focus has expanded beyond viral suppression to the broader issues of overall health, quality of life, and comorbidity management for people living with HIV. The burden of non-communicable , including (CVD), (CKD), and , is becoming more pronounced as this population ages. Thus, modern ART aims not only to prevent disease progression but also to ensure long-term safety, minimize treatment-related toxicities, and reduce cardiovascular and metabolic risks.

👤Authors: Marko Markovic, Jovan Ranin, Aleksa Despotovic, Ivan Rajkovic, Jovana Ranin, Milan Tanasijevic, Nikola Mitrovic, Natasa Nikolic, Ivana Milosevic and Ivana Gmizic

👉Read full paper: https://brnw.ch/21x12Ma

Introduction: Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is recommended for both ART initiation and switch in virologically suppressed patients. We report early real-world outcomes after DOR/3TC/TDF introduction in Belgrade, Serbia. Methods: We conducted a single-center retros...

The   2026 has officially started! We’re excited to be here representing Germs. 🎉📌 25–26 March 2026🌍 The Palace of Parli...
25/03/2026

The 2026 has officially started! We’re excited to be here representing Germs. 🎉

📌 25–26 March 2026
🌍 The Palace of Parliament, Bucharest

If you’re attending, come by to say hello and meet our team — we’d be happy to connect with you!

📸 If you take a picture, don’t forget to tag us — we’d love to share your moments!

And don’t forget: we’re also looking forward to seeing you tomorrow at the Infectious Diseases and HIV Dialogues – 7th Edition!

This paper has received two citations! 🎉📚**Clinical, Epidemiological, and Molecular Aspects of Patients with   in Romani...
23/03/2026

This paper has received two citations! 🎉📚

**Clinical, Epidemiological, and Molecular Aspects of Patients with in Romania**

by Robert Hohan, Ovidiu Vlaicu, Leontina Bănică, Andreea Ioana Tudor, Anca Negru, Simona Paraschiv, and Dan Oţelea

Read here: 📖🔗https://brnw.ch/21x0XRc

🏥 To gain a deeper understanding of the factors influencing the transmission of (mpox) , this study analyzed patients who tested positive for the mpox virus using real-time PCR at one of Bucharest's primary centres.

🦠 This cohort represents one-third of the confirmed mpox cases in Romania.

🌍 Viral Hepatitis: Key Updates & Clinical PerspectivesHow was the global fight against   evolving in 2024?Prof. Dr. Oana...
12/01/2026

🌍 Viral Hepatitis: Key Updates & Clinical Perspectives

How was the global fight against evolving in 2024?
Prof. Dr. Oana Săndulescu et al. summarise the latest advancements in prevention, diagnosis, treatment, and public‑health strategies.

What you need to know:
🧬 Progress across hepatitis A, B, C, D, and E with improved diagnostics and expanded antiviral access
💉 Updated insights on vaccination strategies, screening, and risk‑based prevention
🌍 Focus on equity, decentralised care, and global public health efforts

A timely resource for hepatologists, specialists, and health policy leaders shaping hepatitis care.

🔗 Read the perspective here: https://brnw.ch/21wZ0YH

Adresse

Basel
4052

Webseite

https://x.com/GERMS_MDPI, https://www.linkedin.com/company/germs-mdpi/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von GERMS MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram